A synthetic osmotic cervical dilator is noninferior to oral misoprostol for cervical ripening at term, and its advantages include a better safety profile, less tachysystole, U.S. Food and Drug Administration approval, and better patient satisfaction.
Outpatient cervical ripening with an osmotic cervical dilator significantly reduced hospital stay with no increase in adverse maternal or neonatal outcomes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.